Edgewise Therapeutics Inc. Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while TD SYNNEX Corporation Common Stock trades at $262 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 5.6× Edgewise Therapeutics Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| EWTX | SNX | |
|---|---|---|
Market Cap | $3.94B | $22.02B |
Volume | 810,104 | 614,208 |
Sector | Health | Technology |
52-Week High | $48.35 | $290.14 |
52-Week Low | $14.89 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $26.79B |
Dividend Yield | — | 0.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →